logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
13/02/2026
Market news: Officials say drone invasion caused the closure of El Paso Airport.
Latest
4 m ago
L'Oreal's fourth quarter sales increased by 6% year-on-year, slightly below the market's expectation of 6.46% growth. L'Oreal ADR fell by an expanded 6.8%.
5 m ago
L'Oreal ADR's decline has widened to 6.8%.
5 m ago
L'Oreal ADR fell by 2.2% due to disappointing sales performance in the fourth quarter.
6 m ago
WTI crude oil fell by 3% intraday, now trading at $62.69 per barrel.
6 m ago
Lilly China announced that Mufangda (Irtoboglutide injection) has been approved by the China National Medical Products Administration for use in adults with type 2 diabetes (T2DM) as monotherapy. This approval was based on the SURPASS-CN-MONO study specifically designed for early-stage T2DM patients in China. The results showed that after 40 weeks of treatment with Irtoboglutide as monotherapy, patients demonstrated clinically significant improvements in blood sugar control and weight loss without increasing the risk of hypoglycemia.
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.